The independent source for health policy research, polling, and news.
Liz Szabo was a senior correspondent for Թϲ until December 2023.
Showing 81 - 100 of 112
A woman with foot pain was floored by the high cost of titanium screws used in her surgery. “Unless the metal [was] mined on an asteroid, I do not know why it should cost that amount,” she says.
President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
Sixty-eight percent of those 65 and older take vitamin supplements. Much of what we once believed about the benefits is wrong.
The Centers for Disease Control and Prevention found antibiotic-resistant bacteria whose spread has “outpaced” efforts to contain them.
In a historic move, the Food and Drug Administration stated its intent Thursday to require tobacco companies to cut nicotine levels in their products to make them less addictive. Stripping cigarettes of addictive power could lead an estimated 5 million adults to quit smoking within a year of the plan.
Nearly 1 in 3 Medicare patients undergo an operation in their final year of life.
In an exclusive interview, FDA Commissioner Scott Gottlieb describes what he’s doing to spur competition and bring down drug prices.
Patients are often aggressively screened for cancer, even if they won’t live long enough to benefit.
Overtreatment of breast cancer and other diseases is pervasive, burdening patients and the health care system with enormous costs and needless suffering.
The costs of using a new class of cancer treatments include far more than the drug’s sticker price.
Study suggests that many small tumors are sleepy, not deadly.
The USA's first approved gene therapy — to be used to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment.
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
One in 5 heart attack patients suffers from severe depression, yet many get little or no treatment that could ease their suffering or save their lives.
The Senate health care bill has a provision to increase hospital beds for psychiatric care, but overall cuts in Medicaid could lead to even fewer beds nationwide.
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.
More of the research studies being presented at the world’s largest annual gathering of cancer scientists comes from abroad.
Doctors and drug developers have a stake in making cancer treatments seem better than they really are.
A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 KFF